CORRESP 1 filename1.htm Converted by EDGARwiz



245 Summer Street

Boston, MA 02210


Fidelity® Investments 




 

February 12, 2025


VIA EDGAR


U.S. Securities & Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549


RE:

Variable Insurance Products Fund V (the trust): File Nos. 033-17704 and 811-05361

Strategic Income Portfolio (the fund(s))

Post-Effective Amendment No. 105

Dear Ladies and Gentlemen:

On behalf of Variable Insurance Products Fund V (the Registrant), Post-Effective Amendment No. 105 (the Amendment) to the Registrants registration statement on Form N-1A under the Securities Act of 1933 Act, as amended (the Securities Act), was electronically transmitted for filing pursuant to Rule 485(a) on February 10, 2025 (Accession No. 0000823535-25-000012). The Amendment has been filed solely for the purpose of implementing certain disclosure changes in connection with recent amendments to Rule 35d-1 under the Investment Company Act of 1940, as amended (the Investment Company Act) (the Names Rule).

We hereby request, in reliance upon Securities Act Release No. 6510 and Investment Company Act Release No. 13768 (February 15, 1984), that the Amendment receive selective review from the SEC and its Staff of the changes contained herein. The Amendment reflects the implementation of changes in connection with amendments to the Names Rule, and, aside from the sections highlighted below, the funds prospectus(es) and SAI(s) are not substantially different from the disclosures that were previously filed in Post-Effective Amendment No. 103 (Accession No. 0000823535-24-000120) to the Trusts registration statement on N-1A. The sections of the Amendment that include substantive differences from the prior disclosure include: (i) the Principal Investment Strategies sections of the Fund Summary section in the prospectus; and (ii) the Principal Investment Strategies and Description of Principal Security Types sections in the Investment Details section of the prospectus.

Please contact Renée Fuller at (603) 721-4221 with any questions or comments regarding this Amendment.


Sincerely,




/s/Renée Fuller


Renée Fuller


Shareholder Reporting